← FDA Drug Approvals (Drugs@FDA)
APIXABAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SIGMAPHARM LABS LLC · Approved 2022-02-01
Drug application
- FDA Application #
ANDA210053- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- APIXABAN
- Generic name
- Apixaban
- Active ingredients
- APIXABAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- SIGMAPHARM LABS LLC
- First approval
- 2022-02-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown